6533b7d2fe1ef96bd125ed48
RESEARCH PRODUCT
Oral colonization by Levilactobacillus brevis KABPTM-052 and Lactiplantibacillus plantarum KABPTM-051: A Randomized, Double-Blinded, Placebo-Controlled Trial (Pilot Study)
David BujPol HuedoAnaïs Ramírez-sebastiàJosé NartErola AstóJordi EspadalerSara Jiménez-garridosubject
Dental plaque0301 basic medicinemedicine.medical_specialtySalivaPlaca dental030106 microbiologyPlacebo-controlled studyOdontología616.3PlaceboDental plaqueOdontologiaGastroenterologylaw.invention03 medical and health sciencesProbiotic0302 clinical medicinelawInternal medicinePeriodonciamedicineSalivaGeneral DentistryUNESCO:CIENCIAS MÉDICASbusiness.industryProbioticsProbióticos030206 dentistryPeriodontologyBuccal administrationMicrobiota oralmedicine.diseaseProbiòticsPeriodònciastomatognathic diseasesOral microbiotaDentistryPeriodonticsMild gingivitisbusinessdescription
Background To determine the oral colonization capacity of the strains Levilactobacillus brevis KABPTM-052 (CECT 7480) and Lactiplantibacillus plantarum KABPTM-051 (CECT 7481) in healthy subjects. Material and methods This randomized, double-blinded, placebo-controlled study included 40 volunteers (22 females, 18 males; age range 18-55 years) with healthy gingiva or mild gingivitis, allocated to receiving probiotic chewing gum (n=20) or placebo (n=20) b.i.d for 6 weeks. At baseline and after 6 weeks of treatment, a periodontics specialist collected saliva samples to assess probiotic colonization by qPCR, and analysed dental plaque, gingival index and dental probing pocket depth in Community Periodontal Index (CPI) teeth subset. Protocol was registered as NCT03540498. Results Treatment compliance was high (99%). Both L. brevis and L. plantarum were detected in the oral microbiota at baseline. After 6 weeks, volunteers receiving probiotic showed a significant increase of both L. brevis (p = 0.017) and L. plantarum (p = 0.004) versus placebo. This effect remained significant after adjusting for gender and gingival index at baseline. In the probiotic group, reduction in plaque index significantly correlated to higher levels of L. brevis (rho = 0.57, p = 0.022) but not of L. plantarum at study endpoint, and the number of subjects with dental plaque was reduced during intervention (7 of 17, p = 0.016). No such effects were observed in the placebo group. No adverse drug reactions were reported. Conclusions Levilactobacillus brevis KABPTM-052 and Lactiplantibacillus plantarum KABPTM-051 colonize the buccal microbiota of healthy volunteers, and higher colonization by L. brevis positively correlated to reduction in dental plaque. Key words:Probiotic, Levilactobacillus brevis, Lactiplantibacillus plantarum, oral colonization, oral microbiota, dental plaque.
year | journal | country | edition | language |
---|---|---|---|---|
2021-01-01 | Journal of Clinical and Experimental Dentistry |